Stay updated on Immunotherapy in Stage IV Melanoma Patients Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy in Stage IV Melanoma Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy in Stage IV Melanoma Patients Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now states potential funding-related delays and current NIH Clinical Center operating status, and updates the version to v3.2.0, replacing v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T10:29:56.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T03:23:27.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed as a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-13T17:43:27.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.
    Difference
    0.2%
    Check dated 2025-09-06T15:28:05.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information related to immunotherapy, specifically for Ipilimumab, Pembrolizumab, and Nivolumab, while removing several previous references to locations and certain medical topics.
    Difference
    4%
    Check dated 2025-08-30T12:14:45.000Z thumbnail image
  9. Check
    78 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:41:52.000Z thumbnail image

Stay in the know with updates to Immunotherapy in Stage IV Melanoma Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy in Stage IV Melanoma Patients Clinical Trial page.